Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors.
Cancer Med
; 11(24): 4880-4888, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-35599583
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Liver Neoplasms
/
Lung Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Cancer Med
Year:
2022
Document type:
Article
Affiliation country:
China